title: Are there atrial selective/predominant targets for "upstream" atrial fibrillation therapy?
authors.forename: Alexander
authors.initials: A
authors.lastname: Burashnikov
mesh_terms: D001281:Atrial Fibrillation / Q000235:genetics*; D002304:Cardiac Pacing, Artificial; D022082:Cellular Structures; D020558:GTP Phosphohydrolases / Q000235:genetics*; D006801:Humans; D007249:Inflammation / Q000235:genetics; D053614:Janus Kinase 2 / Q000378:metabolism; D053612:Janus Kinases / Q000378:metabolism*; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D050794:STAT1 Transcription Factor / Q000235:genetics*; D050796:STAT3 Transcription Factor / Q000235:genetics*; D015398:Signal Transduction; D015533:Transcriptional Activation; D014178:Translocation, Genetic; D020830:rac1 GTP-Binding Protein / Q000378:metabolism*
chemical_list: D050794:STAT1 Transcription Factor; C494079:STAT1 protein, human; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D053614:Janus Kinase 2; D053612:Janus Kinases; D020928:Mitogen-Activated Protein Kinases; D020558:GTP Phosphohydrolases; D020830:rac1 GTP-Binding Protein